Select: News

Jul 28, 2010 VaxGen and diaDexus Complete Merger May 28, 2010 VaxGen to Acquire diaDexus in a Stock-for-Stock Merger Under Revised Terms Apr 14, 2010 VaxGen to Acquire diaDexus in a Stock-for-Stock Merger Feb 04, 2010 VaxGen Stockholder Vote Insufficient to Approve Merger with OXiGENE Jan 25, 2010 ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE Sep 25, 2009 VaxGen Congratulates HIV Prime-Boost Vaccine Study Collaborators and Clarifies Commercial Rights Aug 27, 2008 VaxGen Provides Financial Update Following the Filing of Its 10-Q for Second Quarter With SEC; Results Include $8.5 Million Charge in Respect of Manufacturing Plant Asset Impairment Jul 17, 2008 VaxGen receives repayment in full of bridge loan to Raven biotechnologies May 22, 2008 VaxGen restructures Board of Directors May 14, 2008 Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance  [1]  2   3   4   5   6  [ << ] [ < ] [ > ] [ >> ]